Regeneron Pharmaceuticals REGN has outperformed the market over the past 20 years by 14.25% on an annualized basis producing an average annual return of 21.62%. Currently, Regeneron Pharmaceuticals has a market capitalization of $80.23 billion.
Buying $100 In REGN: If an investor had bought $100 of REGN stock 20 years ago, it would be worth $5,006.53 today based on a price of $735.96 for REGN at the time of writing.
Regeneron Pharmaceuticals’s Performance Over Last 20 Years
Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Image and article originally from www.benzinga.com. Read the original article here.